Leveraging Genomics to Advance Precision Cancer Care in Pediatric Solid Tumors- Abelson Hematology-Oncology Lecture
Objectives and Disclosures
- analyze the relative value of different approaches to tumor sequencing in the evaluation of a cancer patient
- interpret the meaning of germline vs somatic alterations in cancer genes.
- evaluate the role of cancer sequencing in the management of cancer
Planners and speaker disclose they have no relevant financial relationships
E. Alejandro Sweet-Cordero, MD
Professor of Pediatrics; Director, Molecular Oncology Initiative Chief of Pediatric Oncology, Department of Pediatrics, UCSF; Professor of Children’s Health, Division of Pediatric Oncology, University of California San Francisco
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.